By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Approves Hepatitis C Drug Incivek from Vertex
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > FDA Approves Hepatitis C Drug Incivek from Vertex
Business

FDA Approves Hepatitis C Drug Incivek from Vertex

BarbaraDuck
BarbaraDuck
Share
3 Min Read
SHARE

There’s a lot of focus on Hepatitis C of late and it was just a couple weeks ago that Merck also received FDA approval for their new drug.  Vertex is up and running with all the patient and physician information posted on their website for additional information and it also has it’s own website: www.incivek.com.  In addition they have included the product in their financial assistance program so those who need

There’s a lot of focus on Hepatitis C of late and it was just a couple weeks ago that Merck also received FDA approval for their new drug.  Vertex is up and running with all the patient and physician information posted on their website for additional information and it also has it’s own website: www.incivek.com.  In addition they have included the product in their financial assistance program so those who need help with affording the drug have options who do not have insurance. 

FDA Approves Merck Victrelis Oral Hepatitis C Virus Inhibitor–New Class of Medicine

It doesn’t stop there as Boehringer has fast track approval and had moved into Phase 3 on their clinical trials so another treatment option is perhaps not too far in the distance.  BD 

Boehringer Ingelheim Receives FDA Fast Track Approval for Hepatitis C Virus Treatment and Moves In To Phase 3 Trials

The US Food and Drug Administration today approved Incivek, a hepatitis C treatment that is expected to be a blockbuster drug for Vertex Pharmaceuticals Inc. of Cambridge.

Last month, a medical advisory committee unanimously recommended that telaprevir, the experimental drug Vertex developed to treat the liver-ravaging hepatitis C virus, be approved by the FDA. The agency typically follows the panel’s advice. Incivek is the brand name that telaprevir will be marketed under.

Vertex has been working on the treatment since 1993. Incivek will become the first drug commercialized solely by Vertex in its 22-year history, a recent Globe story noted.

The company is gearing up to compete with a rival tablet from Merck & Co. in a market that analysts project will initially top $2 billion a year, and could grow to $10 billion or more.

FDA approves potential blockbuster drug for Vertex – White Coat Notes – Boston.com

More Read

Hospital Marketing
Checking In? Why Hospitals Are Offering Services Like Hotels
HIPAA Not an Excuse for Lack of Innovation in Hospitals and Clinics
The Incredible Shrinking Small Business Health Insurance Tax Credit
Why Massachusetts Can Afford Universal Health Insurance
Beyond the Buzz: 20 Tried and Tested Ways to Promote Your Healthcare Blog
T

TAGGED:FDAhepatitis C
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

Government Poised To Provide A Huge Boost To Healthtech Startups

April 17, 2012

Lessons Learned: The Hard Way

November 9, 2011

Medtronic, Infuse and the Senate Finance Committee

June 27, 2011
Screen Shot 2014-04-15 at 7.27.04 AM
BusinessFinanceGlobal Healthcare

The Aesthetics and Reconstructive Surgery Products Global Market

April 16, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?